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Homozygous Defect in HIV-1 Coreceptor Accounts
for Resistance of Some Multiply-Exposed
Individuals to HIV-1 Infection
Rong Liu,* William A. Paxton,* Sunny Choe,* designated EU2 and EU3, required about 1000-fold more
virus to establish infection than contol cells from unex-Daniel Ceradini,* Scott R. Martin,* Richard Horuk,†
posed donors. While a small fraction of the cells didMarcy E. MacDonald,‡ Heidi Stuhlmann,§
become infected with this high inoculum, the virus failedRichard A. Koup,* and Nathaniel R. Landau*
to replicate further. Analysis of the early events of the*Aaron Diamond AIDS Research Center
viral replication cycle showed that macrophage-tropicThe Rockefeller University
HIV-1 isolates failed to enter or fuse to the CD41 cellsNew York, New York 10016
of these two individuals (Dragic et al., 1996). Thus, the†Department of Immunology
resistance of these individuals to sexual transmissionBerlex Biosciences
of HIV-1 was likely to have resulted from the inability ofRichmond, California 94080
their cells to support entry of macrophage-tropic virus.‡Molecular Neurogenetics Unit
HIV-1 can broadly be divided into macrophage- orMassachusetts General Hospital
T-tropic isolates (Gartner et al., 1986; Koyanagi et al.,Charlestown, Massachusetts 02129
1987; Fisher et al., 1988). Macrophage-tropic nonsyncy-§Brookdale Center for Molecular Biology
tium-inducing (NSI) isolates infect primary macrophagesMount Sinai School of Medicine
but fail to infect transformed T-cell lines, while T-tropicNew York, New York 10029
syncytium-inducing (SI) strains have the reciprocal tro-
pism. Both classes of HIV-1 efficiently infect CD41
T-cells isolated from peripheral blood mononuclear cellsSummary
(PBMC). Macrophage-tropic NSI viruses appear to be
preferentially transmitted by sexual contact and consti-Rare individuals have been multiply exposed to HIV-1
tute the vast majority of virus present in newly infectedbut remain uninfected. The CD41 T-cells of two of
individuals (Zhu et al., 1993). The T-tropic SI virusesthese individuals, designated EU2 and EU3, are highly
generally appear late in the course of infection duringresistant in vitro to the entry of primary macrophage-
the so called “phenotypic switch” that often precedestropic virus but are readily infectable with transformed
the onset of AIDS symptoms (Schuitemaker et al., 1992;T-cell line adapted viruses. We report here on the ge-
Connor and Ho, 1994).netic basis of this resistance. We found that EU2 and
HIV-1 replication is initiated by attachment of the virusEU3 have a homozygous defect in CKR-5, the gene
to the cell surface via high affinity binding of the enve-encoding the recently described coreceptor for pri-
lope glycoprotein (Env) to CD4 on the cell surface (re-mary HIV-1 isolates. These individuals appear to have
viewed in Sattentau and Weiss, 1988). Subsequently,
inherited a defective CKR-5 allele that contains an
the viral envelope fuses to the cell membrane, depos-
internal 32 base pair deletion. The encoded protein is
iting the viral core in the cytoplasm. The fusion reaction
severely truncated and cannot be detected at the cell
is mediated by newly described seven transmembranesurface. Surprisingly, this defect has no obvious phe-
domain G protein–coupled molecules termed corecep-
notype in the affected individuals. Thus, a CKR-5 allele
tors (Alkhatib et al., 1996; Choe et al., 1996; Deng et
present in the human population appears to protect
al., 1996; Doranz et al., 1996; Dragic et al., 1996). The
homozygous individuals from sexual transmission of molecular basis of HIV-1 tropism appears to lie in the
HIV-1. Heterozygous individuals are quite common ability of Envs from macrophage-tropic and T-tropic vi-
(z20%) in some populations. These findings indicate ruses to interact with different coreceptors. T-tropic vi-
the importance of CKR-5 in HIV-1 transmission and ruses tend to use Fusin, a previously identified seven
suggest that targeting the HIV-1–CKR-5 interaction transmembrane protein related to the IL-8 receptor
may provide a means of preventing or slowing disease (Feng et al., 1996). Macrophage-tropic viruses primarily
progression. use CKR-5 (for C-C chemokine receptor-5), a newly de-
scribed seven transmembrane domain chemokine re-
Introduction ceptor (Alkhatib et al., 1996; Choe et al., 1996; Deng et
al., 1996; Doranz et al., 1996; Dragic et al., 1996; Feng
The vast majority of people are susceptible to infection et al., 1996). Use of other chemokine receptors such as
with HIV-1. However, rare individuals have been de- CKR-2B and CKR-3 by a minority of viruses has also
scribed that appear to remain uninfected by HIV-1 de- been reported (Choe et al., 1996; Doranz et al., 1996).
spite histories of multiple high-risk sexual exposures to Physiologically, chemokine receptors mediate the
the virus (Clerici et al., 1992; Langlade-Demoyen et al., chemotaxis of T-cells and phagocytic cells to areas of
1994; Rowland-Jones et al., 1995; Paxton et al., 1996). inflammation (reviewed by Horuk, 1994). Upon ligand
While in some cases this may simply be stochastic or binding, the receptors transduce an intracellular signal
may be due to an extremely quiescent infection, Paxton that results in the rapid mobilization of intracellular cal-
et al. (1996) have shown that the CD41 T-cells of some cium. Each of the eight known chemokine receptors
of these individuals resist high doses of virus in vitro. is a G protein–coupled seven transmembrane domain
Of 25 exposed–uninfected (EU) individuals studied, the protein with a characteristic pattern of ligand binding
CD41 T-cells (Paxton et al., 1996) and macrophages (reviewed by Schall, 1991). CKR-5, which also serves
as a major coreceptor for macrophage-tropic HIV-1,(R.I. Connor et al., submitted) of two such individuals,
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binds the b-chemokines RANTES (regulated on activa-
tion, normal T expressed and secreted), MIP-1a (macro-
phage inflammatory protein) and MIP-1b (Samson et al.,
1996). The ligand for Fusin has not yet been identified.
High levels of RANTES, MIP-1a, or MIP-1b prevent repli-
cation of macrophage-tropic, but not T-tropic strains of
HIV-1 (Cocchi et al., 1996). This inhibition is due to the
binding of chemokines to CKR-5, resulting in a block to
viral entry and fusion (Deng et al., 1996; Dragic et al.,
1996). The precise mechanism of this interference is
unknown.
The cellular factors that account for the inability of
macrophage-tropic HIV-1 to enter EU cells have not
been elucidated. Importantly, the CD41 T-cells of EU2
and EU3, while resistant to infection by macrophage-
tropic virus, are readily infected by T-tropic HIV-1 (Pax-
ton et al., 1996). Thus, the EU cells do not have a general-
ized inability to support virus replication. Presumably,
they either lack a specific factor that is required for entry
of macrophage-tropic HIV-1 or contain an inhibitor of
this step of virus replication. T-cell clones derived from
Figure 1. Expression of CKR-1, CKR-5, and Fusin mRNA in EU Cellsthe PBMC of one of these individuals (EU2) generally
RT–PCR amplification of CKR-5, Fusin, CKR-1, glyceraldehydesecreted about 10-fold more b-chemokine than similar
phosphate dehydrogenase (GAPDH) transcripts from the indicatedclones derived from control individuals (Dragic et al.,
EU or normal donor T-cell clones. All RNAs were treated with1996). Thus, the resistance of these cells to HIV-1 infec-
RNAase-free DNase before cDNA synthesis. To confirm the absence
tion could be caused by autocrine or paracrine blocking of contaminating DNA, control cDNA reactions were prepared in
of CKR-5 coreceptor activityby the high levels of endog- which reverse transcriptase was omitted from each reaction. Ampli-
enous chemokines. Alternatively, genetic alteration of fied products were not observed in these controls (data not shown).
GAPDH served as control to confirm equal efficiency of amplificationCKR-5 itself could decrease its ability to mediate viral
of each of the RNAs. Bottom panel shows PCR amplification ofentry.
serial 10-fold dilutions of pcCKR5 plasmid DNA beginning with 1Herewe investigate the geneticbasis of the resistance
ng. 100, (lane 1); 1021 (lane 2); 1022 (lane 3); 1023 (lane 4); 1024 (lane
of the cells from exposed–uninfected individuals EU2 5); 1025 (lane 6); 1026 (lane 7); 1027 (lane 8).
and EU3 to HIV-1 infection. We report that both individu-
als have an identical homozygous defect in the gene
encoding CKR-5. This defect, a 32 bp deletion in the
from four previously characterized EU or normal donorregion corresponding to the second extracellular loop
T-cell clones. EU2-derived cloned T-cell lines (EU2.11,of CKR-5, encodes a severely truncated molecule that
EU2.15, EU2.16, EU2.17), and an EU3-derived T-cellfails to reach the cell surface. As a result, the cells are
clone (EU3.1) are resistant to macrophage-tropic virus,resistant to infection by macrophage-tropic virus. It is
while two clones from unexposed control donorslikely that the defect in CKR-5 is primarily responsible
(LW4.39 and LW5.49) are sensitive to both macrophage-for the ability of these individuals to remain uninfected
tropic and T-tropic virus (referred to as LW4.13 andfollowing repeated exposure to HIV-1. Furthermore
LW5.8 in Dragic et al., 1996). Clones EU2.11, EU2.15,these findings suggest an essential role for CKR-5 in
EU2.16, and EU3.1 were also found to be somewhatthe sexual transmission of HIV-1.
resistant to T-tropic virus, while clone EU2.17 was
readily infectable (Dragic et al., 1996). Results of RT–
PCR analysis showed that CKR-5, CKR-1, and fusin tran-Results
scripts were at least as abundant in the EU2 and EU3
cells as in those of normal donors (Figure 1). CKR-5 andExpression of Coreceptors in EU-Derived Cells
CKR-1 transcripts appeared to be present at slightlyAt least two mechanisms could account for the resis-
elevated levels in EU cells as compared with controls,tance of EU cells to infection by macrophage-tropic
perhaps due to decreased negative feedback control ofviruses. Overproduction of b-chemokines in these cells
transcription of these genes. Thus, the resistance ofcould lead to receptor desensitization and down-regula-
EU2 cells to macrophage-tropic HIV-1 was unlikely totion of CKR-5, inhibiting its coreceptor function. Alter-
be due to the absence or insufficient expression of thenatively, a failure to synthesize functional cell surface
coreceptor gene.coreceptor caused, for example, by inadequate tran-
scriptional activity of the CKR-5 gene or alteration of
the CKR-5 coding sequence could account for the resis- CKR-5 Transcripts from EU Cells Do Not
Encode Active Coreceptortance of these cells to infection. To assess the relative
amounts of CKR-5 and other coreceptor transcripts in We previously showed that CKR-5 and Fusin coreceptor
function can be sensitively detected in a transient trans-EU cells, we used reverse transcription-polymerase
chain reaction (RT–PCR) to amplify CKR-5, fusin, and fection assay (Deng et al., 1996). In this assay, 293T
human embryonic kidney cells are transfected with CD4CKR-1 cDNAs from equivalent amounts of RNA isolated
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and CKR-5 expression vectors. The cells are then in-
fected with single-cycle luciferase reporter virus derived
from the HIV-1 provirus pNL-Luc-Env2 (Connor et al.,
1995). This vector is a modified form of the HIV-1 provi-
rus NL4-3 in which a firefly luciferase gene replaces nef
and a frameshift mutation has been inserted in env. As
a result of the frameshift in env, the virus is restricted
to a single-cycle of replication. Following infection and
integration of this virus, the luciferase reporter gene is
expressed, reflecting the efficiency with which the virus
entered. Pseudotyping this reporter virus with different
HIV-1 Envs allows measurement of the relative activity
of different coreceptors. Reporter viruses pseudotyped
by macrophage-tropic Envs JRFL, BaL, or ADA are spe-
cific for CKR-5 while those pseudotyped by the T-tropic
Env HXB2 use Fusin for entry. Reporter virus pseu-
dotyped by amphotropic murine leukemia virus (A-MLV)
Env (Page et al., 1990; Landau et al., 1991), which enters
through a noncoreceptor pathway, was used in these
experiments to rule out postentry effects on luciferase
expression.
We used the transient transfection assay to test the
coreceptor function of EU2 and EU3 CKR-5. CKR-5
cDNAs were amplified from EU2, EU3, or normal donor
RNA by RT–PCR and cloned into the expression vector
pcDNAI/amp. Each CKR-5 expression vector was then
mixed with an equal amount of CD4 expression vector
and used to transfect 293T cells. Coreceptor function
encoded by each CKR-5 expression vector was mea-
sured by infecting the transfected cells with the panel
of single-cycle luciferase reporter viruses. The results
showed that normal donor-derived CKR-5 expression
vector encoded coreceptors that mediated efficient en-
try of macrophage-tropic virus (Figure 2A, WT). In con-
trast, the CKR-5 expression vectors derived from each Figure 2. EU CKR-5 Does Not Function as an HIV-1 Coreceptor
of the five EU2 and EU3 cell lines were inactive. The
(A) CKR-5 expression vectors were tested in transient assay for
failure of these expression vectors to encode functional ability to mediate entry of macrophage-tropic virus. 293T cells were
CKR-5 is not likely tohave been the result of misincorpo- cotransfected with pcDNAI/amp expression vectors for CKR-5
cDNAs derived from indicated EU2, EU3, or normal donor cell linesration during RT–PCR. RT–PCR amplified CKR-5 from
and with CD4 expression vector pcCD4. To test for possible domi-control cells has in every case to date (at least four
nant negative activity, wild-type and EU-derived CKR-5 expressionindependent repetitions) resulted in functional CKR-5
vectors were mixed in a 1:1 ratio and used to transfect 293T cells.cDNA. In addition, RT–PCR amplification of CKR-5 from
The cells were infected with the indicated luciferase reporter viruses
EU2 or EU3 has not yielded a single functional cDNA (10 ng p24gag) pseudotyped by macrophage-tropic (JRFL, ADA, BaL),
in at least seven independent repetitions. Furthermore, T-tropic (HXB2), or A-MLV Env. Luciferase activity was measured
three days later as described in Experimental Procedures. This ex-fusin cDNA amplified from these same RNA preparations
periment has been repeated three times with similar results. Wild-(described below) was uniformly active, arguing against
type CKR-5 has been amplified from three different cell lines anda global defect in EU RNA. To determine whether the
showed similar activity to that shown here. BaL Env typically resultsinactive CKR-5 cDNAs encoded a product with domi-
in significantly lower infectivity than the other two macrophage-
nant negative activity, equal amounts of active and inac- tropic Envs (Deng et al., 1996). Error bars indicate standard deviation
tive CKR-5 expression vector were mixed with CD4 ex- of duplicate independent measurements.
pression vector and used to transfect 293T cells. The (B) HOS.CD4 cells stably expressing fusin cDNAs or containing con-
trol pBABE-puro vector alone were infected with luciferase reporteraddition of inactive CKR-5 vector did not reduce the
viruses as in (A). These cells have very low levels of endogenouscoreceptor activity of the wild-type CKR-5 (Figure 2A),
Fusin expression and become very susceptible following transfec-arguing against a dominant negative role for the non-
tion (data not shown).
functional gene.
We used a similar approach to determine whether
function of the expressed Fusins was then determinedFusin derived from EU cells was active as a coreceptor.
by infecting the cellswith luciferase reporter viruses. Thefusin cDNAs were amplified by RT–PCR and cloned into
results showed that EU-derived fusin cDNAs encodedthe murine leukemia virus-based retroviral vector,
coreceptors that mediated entry of T-tropic HIV-1 atpBABE-puro (Morgenstern and Land, 1990). These vec-
levels comparable to that of the wild-type (Figure 2B).tors were then used to establish HOS. CD4 (He and
Similar results were obtained with fusin cDNA derivedLandau, 1995) (human osteosarcoma cells expressing
CD4) stably expressing EU2-derived Fusin. Coreceptor from EU3 (data not shown). Thus, the cells of these
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Figure 3. EU CKR-5 Containsa 32 bp Internal
Deletion
(A) The nucleotide sequences of wild-type
CKR-5 derived from normal donor (above)
and EU cDNAs (below) are shown. The nucle-
otide sequence from normal donor CKR-5
cDNA was determined for the complete 1055
bp codingsequence and foundto be identical
to that reported by Samson et al. (1996). The
nucleotide sequence of 2 EU CKR-5 cDNAs
were identical to wild-type over the complete
coding region with the exception of a 32 bp
deletion. Nucleotide sequence of the 200 bp
region of CKR-5 encompassing the deletion
was also determined for cDNAs derived from
clones EU2.11, EU2.15, EU2.16, EU2.17, and
EU3.1. Each contained the identical deletion
with no additional nucleotide changes. Only
the region flanking the deletion is shown. The
deleted region (nt 794 to 825) is shaded. Amino acids encoded out of frame as a result of the deletion beginning at codon 185 are shown in
italics. Nucleotide numbering (above) is from the first nucleotide of the reported CKR-5 sequence (Samson et al., 1996). Amino acid residue
numbers are shown below.
(B) Oligonucleotide primers used for nucleotide sequencing of CKR-5 cDNA and detecting the deleted allele by PCR. The coding region is
indicated by dark shading. Primers have been designated by nucleotide position at which they hybridize. Oligonucleotides used in PCR for
detecting the deletion are shown as lightly shaded arrows. Oligonucleotides for cloning the full-length cDNA are shown at either end.
individuals are likely to contain fully functional Fusin. with a single exception. In one EU2-derived CKR-5
cDNA, a single G to A change at nt 559 that encodesThe reason that some T-cell clones from EU2 support
T-tropic virus replication at levels somewhat reduced an Arg to Lys change was found. This alteration was
not present in any of the three other EU2 CKR-5 cDNAsto that of control cells (Dragic et al., 1996) is not clear
but could be due to a slight decrease in the amount of sequenced and may have arisen by misincorporation
during RT–PCR.coreceptor on the cell surface or to increased synthesis
of the yet uncharacterized Fusin ligand. In addition,
CKR-1 cDNA amplified from EU2 RNA was fully active
in mobilizing intracellular calcium upon binding to Defective CKR-5 Is Encoded in the Genomic
RANTES or MIP-1a (data not shown). These findings DNA and Inherited
strongly suggest that EU2 and EU3 express CKR-5 The 32 bp deletion found in EU CKR-5 RNA could have
mRNA that does not encode a functional HIV-1 corecep- resulted from an aberrant splice to cryptic splice sites
tor. Thus, the resistance of EU2 and EU3 to infection by or could have been due to the presence of the deletion
macrophage-tropic HIV-1 strains is likely to be due to in the CKR-5 gene itself. To distinguish between these
geneticalteration of CKR-5. Furthermore, the EU pheno- possibilities, we amplified a portion of CKR-5 containing
type is not the result of a generalized defect in several the deleted region from EU2, EU3, and control donor
coreceptors, but is likely to be restricted to a defect in genomic PBMC DNA. PCR amplification using the flank-
CKR-5. ing primers SP4.760 and PM6.942 (Figure 3B) yields
predicted fragments of 182 bp and 150 bp for the wild-
type and deleted alleles, respectively. PCR amplificationEU CKR-5 RNA Contains a 32 Base Coding
Sequence Deletion from EU2 and EU3 genomic DNA with these primers
showed only the 150 bp band (Figure 4, lanes 3 and 5).To define the predicted genetic alteration, we deter-
mined the nucleotide sequence of the complete 1055 In contrast, only the 182 bp band was amplified from
LW5 control donor DNA. These findings confirmed thebp coding region of CKR-5 cDNA clones derived from
EU2, EU3, and a normal donor. Nucleotide sequences presence of the CKR-5 deletion in the genomic DNA of
both EU individuals. In addition, we examined the CKR-5were determined on both strands using the set of prim-
ers shown in Figure 3B. This analysis revealed an identi- alleles of 13 of the remaining 23 EU individuals in the
cohort. Only one other individual’s CD41 cells werecal 32 bp deletion in each of the EU2 and EU3 cDNAs.
The deletion spans nucleotides 794 to 825 in a region highly resistant to infection, and the genomic DNA of
this individual had only deleted CKR-5. The other 22corresponding to the second extracellular loop of the
receptor (Figure 3A). The deleted allele encodes a 215 samples were either fully or partially infectable (Paxton
et al., 1996) and of those tested, only wild-type CKR-5amino acid protein (the wild-type receptor is 352 amino
acids) in which the C-terminal 31 amino acids are trans- allele was present (data not shown).
To rule out possible PCR-related artifacts, the CKR-5lated out of frame. This deletion was present in all four
independently amplified EU2 CKR-5 cDNAs and in the allele status of these individuals was confirmed by geno-
mic Southern blot analysis. High molecular weight DNAtwo EU3 cDNAs sequenced. Each of six cDNAs ampli-
fied from normal control T cell clones LW4.39 and isolated from PBMC of EU2, EU3, and EU39s parent
and a normal donor was cleaved with EcoRI and BglIILW5.49 was identical to wild-type CKR-5, as was a sin-
gle CKR-5 amplified from PBMC of another control un- restriction endonucleases. This releases a 283 bp wild-
type or 251 bp deleted fragment. Southern analysis con-exposed individual. In each EU-derived cDNA, no nucle-
otide changes were noted outside the 32 bp deletion, firmed that EU2 and EU3 DNA contains only the deleted
Exposed–Uninfected Coreceptor Mutation
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the gene to the short arm of chromosome 3 in cytoge-
netic band 3p21. Thus, CKR-5 is linked to other mem-
bers of the chemokine receptor family including CKR-1,
CKR-2, V28, and CMKBRL1 that are also on 3p21 (Baggi-
olini et al., 1995; Combadiere et al., 1995; Raport et al.,
1995). The autosomal localization of CKR-5 predicts that
its inheritance is not sex-linked.
EU2 and EU3 Are Homozygous
for the CKR-5 Deletion
The analysis described above is consistent with a homo-
zygous CKR-5 deletion in EU2 and EU3. However, it is
equally consistent with a hemizygous status in which
loss of a portion of one parental chromosome 3 resulted
in complete loss of CKR-5. To distinguish between these
possibilities, we analyzed the CKR-5 locus in normal
donor and EU2 genomic DNA. Genomic DNAs from the
PBMC of a normal donor, from two normal donor T-cell
clones (LW4.39 and LW5.49), and from an EU2 T-cell
Figure 4. The EU CKR-5 Deletion Is Present in Genomic DNA clone was cleaved with EcoRI, PvuII, or HindIII and hy-
(A) CKR-5 was amplified by PCR from genomic DNA of indicated EU, bridized to a full-length 32P-labeled CKR-5 probe. For
EU parent, or normal control PBMC. Primers SP4.760 and PM6.942 all four genomic DNAs, the probe hybridized to bands
(shown in Figure 3) that flank the deletion were used to generate of similar lengths with the following exceptions. First,
wild-type and deleted fragments of 182 bp and 150 bp, respectively.
EcoRI and HindIII digests of EU2 DNA showed CKR-5DNA from the other parents was unavailable. Control reactions in
fragments of 1.2 kb and 2.0 kb, respectively, that werewhich DNA was omitted from the PCR had no amplified product
slightly smaller than those of the control DNAs (Figure(data not shown). Sizes of marker fragments are indicated at left in
base pairs. 5, lanes 4 and 8, arrows). This decrease is consistent
(B) Genomic DNA (10 mg) isolated from PBMC of the indicated with the presence of the 32 bp deletion, further support-
donors was digested with EcoRI and BglII and hybridized to a 32P- ing thepredicted presence of the deletion in thegenomic
labeled CKR-5 probe. The position of the wild-type and deleted
DNA of EU2. Second, the CKR-5 of LW5.49 contains afragments is indicated by arrows.
PvuII restriction fragment length polymorphism (RFLP)
(Figure 5, lane 11). An additional PvuII site in this DNA
results in the appearance of a 2.9 kb band in addition
allele, while the parent of EU3 has wild-type and deleted to the common 3.4 kb band. Both CKR-5 bands are
alleles (Figure 4B). decreased in intensity as compared with that of the
The finding that two unrelated EU individuals have other three samples (Figure 5, compare lane 11 with
identically deleted CKR-5 alleles suggests that this mu- lanes 9, 10, and 12). This decrease reflects the twofold
tation originated in a common ancestor and was inher- decrease in copy number of each fragment in thehetero-
ited through the germline. Mendelian inheritance of zygote. Thus, the difference between a haploid or diploid
these alleles would require that the parents of a homozy- CKR-5 content is detectable in this analysis. Similarly,
gous EU individual are themselveseither homozygous or in the EcoRI and HindIII digests the CKR-5 fragment of
heterozygous for the deletion. Alternatively, the deletion EU2 DNA is similar in intensity to that of the three control
could have arisen de novo as the result of a recombina- samples. In addition, Southern analysis of EU3 genomic
tion hot spot. To distinguish between these possibilities, DNA showed only the deleted CKR-5 fragment (data not
we determined the CKR-5 status of the available paren- shown). Together, these findings suggested that EU2
tal genomic DNA of these individuals. For both EU2 and and EU3 were homozygous for the deleted allele and
EU3, the tested parent appeared to be heterozygous that no gross rearrangement of chromosome 3 was as-
(Figure 4A, lanes 4 and 6), with one chromosome having sociated with the deletion.
the deleted and the other having the wild-type allele
(DNA from the other parent of each individual was un-
available). Thus, it is likely that for both individuals each EU Cells Do Not Express Functional CKR-5
parent transmitted a deleted allele to their offspring. Serological reagents are not currently available to detect
However, because of the unavailability of DNA from the CKR-5. We therefore used two methods to investigate
other parent, we could not demonstrate this definitively. whether the EU cells expressed functional CKR-5. In the
To determine whether inheritance of the deleted first, we tested whether epitope-tagged EUCKR-5 could
CKR-5 allele could have been sex-linked in EU2 and be expressed on the cell surface. To do this we con-
EU3, both of whom are males, we determined the chro- structed vectorsexpressing EU2, EU3, orwild-type influ-
mosomal localization of the gene. CKR-5 was amplified enza hemagglutinin (HA)-tagged CKR-5. These were
from genomic DNAs of two somatic cell hybrid mapping mixed with an equal amount of CD4 expression vector
panels (data not shown). The first panel localized the to control for transfection efficiency, and used to cotran-
CKR-5 gene to chromosome 3. The second, a panel of sfect 293T cells. Fluorescence-activated cell sorter
(FACS) analysis of the cells stained with anti-HA MAbradiation hybrids (Naylor et al., 1996), further localized
Cell
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(Figure 6C). Thus, EU2 cells do not transduce CKR-5-
mediated signals, yet are fully competent to transduce
signals through other chemokine receptors. EU2 cells
therefore do not have a generalized deficiency in their
ability to transduce signals from other chemokine re-
ceptors.
Deleted CKR-5 Heterozygotes Are Common
and Their Cells Can Be Infected In Vitro
Resistance to HIV-1 infection is rare. Of a large number
of PBMCs from random blood donors, all were readily
infected by T-tropic and macrophage-tropic HIV-1 (Spira
and Ho, 1995, and data not shown). Because the pool
size from which EU2 and EU3 were selected is unknown,
we were not able to estimate the frequency of resistant
individuals. To estimate the allele frequency in a popula-
tion with a genetic background similar to that of EU2
and EU3 (both are of European descent), we tested a
panel of genomic DNAs (MacDonald et al., 1991, 1992)
isolated from unrelated individuals of western European
origin. Of the 44 samples tested, 10 (22.7%) were hetero-
zygous for the deletion, and the rest showed only the
wild-type allele (Figure 7A). The heterozygous status
of these samples was confirmed by genomic Southern
analysis (Figure 7B and data not shown). Two other
panels of genomic DNAs (MacDonald et al., 1991, 1992)
isolated from individuals of western European originFigure 5. EU2 Is Homozygous for Deleted CKR-5
showed a 15.6% (5 out of 32) and 19.6% (9 out of 46)
Genomic DNA from normal donor PBMC, from normal donor T-cell
frequency of heterozygotes (data not shown). Thus,clones LW4.39 and LW5.49, and from EU2-derived T-cell clone
among the 122 samples tested, 24 were heterozygousEU2.11 was cleaved with indicated restriction enzyme. The cleaved
yielding a calculated allele frequency of 0.098. AssumingDNA was separated by agarose gel electrophoresis and hybridized
to a 32P-labeled CKR-5 cDNA probe. Arrows indicate CKR-5 frag- Hardy-Weinberg equilibrium, this predicts frequencies
ments. The 22 kb band in the EcoRI digests is derived from a frag- of 81% wild-type homozygotes, 18% heterozygotes,
ment containing the 39-end of CKR-5. The other faint high molecular and 1% homozygotes for deleted CKR-5 in populations
weight bands are likely to correspond to CKR-2, which is closely
of western European heritage. In a preliminary analysisrelated in nucleotide sequence. High stringency washing of similar
of individuals from other backgrounds, genomic DNAsfilters in pilot experiments removed these bands. CKR-5 bands from
from members of the Venezuela reference mapping re-EU2 are equal in intensity to those of controls, suggesting diploid
content. Intensity of a fragment with a haploid content is shown source (Locke et al., 1988; Tanzi et al., 1988) were tested.
by PvuII digest of LW5.49 who is heterozygous for a PvuII RFLP. No deleted alleles were present in the 46 genomic DNAs
Molecular size markers are indicated at left in kilobases. tested. Thus, the allele is common in some human popu-
lations but much rarer in others. These findings suggest
a rather recent evolutionary origin of this mutation.
revealed that HA-tagged wild-type CKR-5 was ex- Individuals that are heterozygous for the CKR-5 dele-
pressed at thecell surface (Figure 6A, upper right). Infec- tion could express less coreceptor and as a result repli-
tion studies showed that this protein retained its core- cate virus less efficiently. In a preliminary analysis of
ceptor activity (data not shown). In contrast, HA-tagged the infectability of heterozygous cells, we measured the
CKR-5 derived from EU2 or EU3 was not detected (Fig- replication efficiency of a macrophage-tropic HIV-1
ure 6A, lower panels). Immunoblot analysis of the strain, SF162, on the CD41 T-cells of EU2, EU3, and one
transfected cells suggested that the mutant protein was parent of each. The cells of LW5 were used as a source
not stably expressed in the cytoplasm (Figure 6B). of wild-type cells. In this analysis, virus replicated effi-
ciently on the wild-type cells, failed to replicate on the
EU cells, and replicated to an intermediate level on bothEU2 Cells Do Not Transduce
parental T-cells (Figure 7C). This finding suggested thatCKR-5-Mediated Signals
heterozygous cells are somewhat reduced in their abilityTo determine whether PBMC from EU individuals ex-
to replicate macrophage-tropic HIV-1.press functional chemokine receptors, we measured in-
tracellular [Ca21] levels in response to challenge with the
b-chemokines MIP-1b and RANTES. When control cells Discussion
were loaded with the calcium probe Fura 2 and chal-
lenged with physiological concentrations of MIP-1b fol- We show here that two individuals who are resistant
to HIV-1 infection in spite of repeated exposures arelowed by RANTES, a rapid increase in intracellular [Ca21]
was observed (Figure 6C). In contrast, PBMC from EU2 homozygous for a defect in the gene encoding CKR-5, a
major coreceptor for macrophage-tropic HIV-1 isolates.were refractory to MIP-1b but responded to RANTES
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Figure 6. EU CKR-5 Is Not Detectable at the
Cell Surface or in the Cytoplasm and Does
Not Transduce Intracellular Signals
(A) 293T cells were cotransfected with equal
amounts of CD4 expression vector pcCD4
and indicated wild-type CKR-5 (HA-CKR5),
EU CKR-5 (HA-CKR5.EU2.16 and HA-CKR5.
EU3.1), or control pcDNAI/amp vector. Two
days later, the cells were stained with FITC-
conjugated anti-CD4 MAb Leu3a, anti-HA
MAb 12CA5, and phycoerythrin-conjugated
second antibody. Expression vectors for EU
HA-CKR-5 were derived from T-cell clones
EU2.16 and EU3.1, as indicated. The number
of cells staining positive for both the HA epi-
tope and CD4 is indicated as the percentage
of cells falling in the upper right quadrant.
Untransfected cells did not stain significantly
with either antibody (data not shown).
(B) The transfected cells were lysed and cyto-
plasmic HA-tagged CKR-5 was detected on
immunoblots probed with anti-HA MAb.
CKR-5 appears as an extremely heteroge-
neous band extending from 40 kDa to the
origin. The heterogeneous mobility of CKR-5
on SDS–PAGE appears to be a property of
this family of proteins since similar results
were found on immunoblots probed for
CKR-1 (data not shown).
(C) EU cells fail to increase intracellular [Ca21]
in response to MIP-1b. PBMC from EU2
or normal control donor were loaded with
the calcium probe Fura 2 and exposed to
MIP-1b and then RANTES (100 nM each) at the times indicated by arrows. Intracellular [Ca21] was measured by spectrofluoremetry as described
in Experimental Procedures. Chemokine binding assay showed that cells from EU2 bound 2- to 3-fold less MIP-1b than control. Both bound
similar amounts of RANTES (data not shown).
Both individuals have identical CKR-5 alleles containing nature of the chemokine system. Several members of
the chemokine receptor family have overlapping liganda 32 bp deletion in a region of the gene corresponding
to the second extracellular loop. The deletion results in reactivities and tissue distribution. Thus, in individuals
homozygous for the defective allele, the loss of CKR-5a frameshift that encodes a severely truncated protein
which is not detected at the cell surface or in the cyto- might be compensated by a chemokine receptor such
as CKR-1, that has a similar ligand profile. By analogy,plasm. The absence of CKR-5 from these cells explains
their inability to transduce signals in response to MIP- rare individuals have been reported that do not express
the erythrocyte chemokine receptor, DARC (Duffy anti-1b. The reason for their enhanced secretion of b-chemo-
kines is not clear, but could have to do with decreased gen), as a result of a 14 bp deletion in the coding se-
quence (Mallinson et al., 1995). As in the case of CKR-5,up-take of chemokines as a results of the missing chem-
okine receptor or with increased chemokine expression no phenotype was associated with that deletion.
due to a lack of negative regulatory signals that normally
reduce chemokine synthesis.
These findings suggest that the homozygous deletion Frequency and Evolution of the Deleted
CKR-5 Allelein CKR-5 accounts for the resistance of these two indi-
viduals to transmission of HIV-1. While it is conceivable The deleted allele was present in a surprisingly high
percentage of unrelated individuals of western Euro-that a second, yet undetected defect contributed to
their resistance, the finding that the EU cells were fully pean heritage (z20% heterozygotes). In contrast, it was
present at much lower frequency in a panel of individualsinfectable by A-MLV pseudotypes and by T-tropic HIV-1
argues against the presence of a secondary defect. The from Venezuela. Assuming Hardy-Weinberg equilibrium,
the frequency of CKR-5-deleted homozygotes is aboutCKR-5 deletion is not, however, likely to account for the
resistance to infection of all EU individuals. Individuals 1% in the general population of persons with western
European heritage. The CKR-5 allele status of HIV-1whose cells are only partially resistant to primary HIV-1
infection could express CKR-5 alleles with reduced cor- infected individuals remains to be determined. Presum-
ably, infected individuals who are homozygous for de-eceptor activity. EU individuals whose cells were fully
infectable may resist infection by a yet undefined mech- leted CKR-5 are extremely rare. If transmission through
a CKR-5-independent route occurs infrequently, homo-anism.
Both individuals are healthy, without any obvious clini- zygous individuals would not be completely protected.
A large-scale analysis to determine the frequency of thecal conditions. The absence of a phenotype associated
with the CKR-5 defect may result from the redundant deleted CKR-5 allele among HIV-1 infected individuals
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continually generates these alleles in the population. It
is difficult to estimate when this deletion first occurred;
however, its restricted distribution and the absence of
secondary mutations in the gene suggest a rather recent
evolutionary origin.
There is no reason to believe that the high frequency of
heterozygotes among individuals of western European
ancestry was due to selection pressure from the virus
since HIV-1 has only recently become endemic to this
population. However, it is possible that in areas where
HIV-1 has been endemic for considerably longer periods
of time, a selective advantage would be provided to
individuals heterozygous or homozygous for this or simi-
lar CKR-5 alleles that may be present in these popula-
tions. Precedence for selective pressure to lose expres-
sion of a chemokine receptor is provided by theexample
of the erythrocyte chemokine receptor, DARC. A mutant
DARC allele that cannot be expressed in erythrocytes
provides resistance to Plasmodium vivax (Horuk et al.,
1993). Individuals carrying this allele may have a selec-
tive advantage in areas where the parasite is endemic.
Whether there is an advantage to heterozygosity for
deleted CKR-5 is not clear. While heterozygous cells
had a somewhat reduced ability to replicate HIV-1 (4-
to 10-fold less virus production), it is not clear whether
this magnitude of decrease would offer significant pro-
tection against sexual transmission. Whether there is
any protection offered to heterozygotes could be deter-Figure 7. The Deleted CKR-5 Allele Is Frequent in Some Populations
mined by comparing the frequency of the deleted allele
(A) CKR-5 alleles amplified from 42 genomic DNAs from individuals in HIV-1-infected, HIV-1-exposed but uninfected, and
of western European heritage in the CEPH reference mapping re-
nonexposed individuals. Such an advantage has beensource (MacDonald et al., 1991) (excluding codes 102 and 104).
described in the case of b-globin mutations. The erythro-CKR-5 sequences were amplified using primers SP4.760 and
cytes of individuals heterozygous for a mutation inPM6.942 (shown in Figure 3) flanking the 32 bp deletion, generating
wild-type and deleted fragments of 182 bp and 150 bp, respectively. b-globin are resistant to Plasmodium falciparum. As a
Positions of markers are indicated at right in base pairs. PCR prod- result, the frequency of the mutant allele is high in sub-
ucts were separated on 4% Metaphor agarose. Reactions con- Saharan Africa (Wiesenfeld, 1968). Selection for the de-
taining no genomic DNA showed no amplified product (NEG). PCR
leted CKR-5 allele, or for other yet unknown CKR-5 poly-amplification of pcCKR5 plasmid DNA showed only the 182 bp band
morphisms might be most evident in areas of Africa that(POS). Weak amplification of sample 29 may have been due to low
have a high incidence of HIV-1 infection.genomic DNA concentration. In heterozygous samples (1, 6, 16, 17,
18, 20, 30, 34, 35, 37) the bands have decreased intensity as com-
pared with homozygotes, as expected. The deleted allele is always
less intense than the wild-type band, possibly as a result of its Implications for Pathogenesis
smaller size. Two samples that amplified weakly but were wild-type and Transmission of HIV-1
are not shown. Thus, the frequency of heterozygous individuals in
In vitro, seven transmembrane domain proteins in addi-this population is 22.7%.
tion to CKR-5, such as Fusin, CKR-2B, and CKR-3, have(B) Southern analysis of selected heterozygous samples. Genomic
DNA from T-cell clone EU2.15 (lane 1), selected heterozygous sam- been shown to act as coreceptors for various HIV-1
ples 30 (lane 2), 34 (lane 3), 35 (lane 4), and 37 (lane 5) and a control isolates. The relative frequency with which each of these
donor were cleaved with BglII and EcoRI and hybridized to a full- coreceptors is used in vivo is not known. Our findings on
length [32P-a]dCTP-labeled CKR-5 probe. Wild-type and deleted the resistance of multiply exposed individuals to HIV-1
CKR-5 fragments are indicated.
infection demonstrate the critical role of CKR-5 in vivo. It(C) Growth of macrophage-tropic HIV-1 on CD41 cells heterozygous
is highly likely that HIV-1 transmission typically proceedsfor CKR-5. Activated CD41 cells from indicated donorswere infected
with macrophage-tropic HIV-1 strain SF162. Virus replication was through a CKR-5-dependent event. Fusin and at least
measured by determining the amount of p24gag present in the cul- some of the other CKR genes appeared to be unaltered
tures at the indicated days postinfection. This experiment has been in the EU individuals. Thus, these receptors appear to be
repeated with similar results using luciferase reporter viruses. insufficient for sexual transmission of common strains of
the virus.
Given their high numbers of exposures, it is likely thatwould permit calculation of the extent to which homozy-
gosity protects against infection. the EU individuals have been exposed to NSI, as well
as SI viruses. These individuals have functional FusinIt is likely that the deleted CKR-5 allele in the majority
of heterozygous and homozygous individuals is inher- and other HIV-1 coreceptors, yet do not become in-
fected. It may be that CD41 cells expressing the otherited. This was suggested by our finding that EU2 and
EU3 both had at least one heterozygous parent. Further- coreceptors are not prevalent among the cells that line
the mucosal surfaces at which transmission occurs. Al-more, our finding that the deletion was identical in every
individual makes it unlikely that a recombination hot spot ternatively, transmission followed by systemic spread
Exposed–Uninfected Coreceptor Mutation
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RNAase-free DNAase (Boehringer-Mannheim). Oligo-dT-primedof virus may be supported only by specific cell-types
cDNA was prepared from 5 mg RNA using Superscript reverse tran-that express CKR-5 but not Fusin or other potential
scriptase (GIBCO–BRL) according to the manufacturer’s instruc-HIV-1 coreceptors. Infection by SI virus of CD41 T-cells
tions and resuspended in 80 ml TE (10 mM Tris [pH 8.0], 1 mM EDTA).
could occur transiently following sexual contact but may Aliquots of the cDNA (5.0 ml) were amplified with Taq polymerase
not result in systemic spread of thevirus. Further replica- (Boehringer-Mannheim) by 5 cycles of PCR (948C, 30 s; 558C, 45 s;
728C, 90 s) followed by an additional 35 cycles (948C, 30 s; 628C,tion of the virus might require infection of specialized
45 s; 728C, 90 s) in a volume of 50 ml using primers hybridizing tocells such as macrophages that cannot be infected by
the 59 and 39 untranslated regions of CKR-5. The reaction productsSI viruses which use Fusin as coreceptor. The properties
(10 ml) were separated on 1% agarose (FMC) in the presence of 0.5of CKR-51 cells such as macrophages that allow them
mg/ml ethidium bromide and photographed. A control amplification
to support systemic spread of HIV-1 are not yet defined, containing no added DNA was included in each experiment reaction.
but may be related to their ability to activate T-cells. No PCR product was detected in these reactions. For cloning of
amplified cDNAs, PCR was carried out similarly except that insteadTransmission of SIvirus could result in an abortive infec-
of Taq polymerase a high fidelity Expand polymerase (Boehringer-tion that is sufficient to establish anti-viral cytolytic
Mannheim) was used for a total of 37 cycles. Amplified productsT-cells, but which is soon cleared. Rowland-Jones et
were digested with BamHI and SalI restriction enzymes for CKR-5al. (1995) have recently described a cohort of Gambian
or HindIII and XhoI for Fusin. CKR-5 cDNAs were cloned into the
prostitutes that have been heavily exposed to HIV-1 but cytomegalovirus promoter-driven expression vector pcDNAI/amp
remain uninfected. This phenomenon was associated (Invitrogen Corporation). fusin cDNAs were cloned into the retroviral
expression vector pBABE-puro (Morgenstern and Land, 1990). Nu-with a cellular immune response against the virus. The
cleotide sequencing of the cloned cDNAs was determined by thepresence of cytotoxic T lymphocyte responses against
dideoxy method on both strands using primers shown in Figure 3B.HIV-1 in these individuals is consistent with a transient
Upstream and downstream oligonucleotide primers for amplifyinginfection. It will be important to determine the CKR-5
and cloning were as follows: CKR-5: 59-CTCGGATCCGGTGGA
status of such individuals. ACAAGATGGATTAT, 59-CTCGTCGACATGTGCACAACTCTGACTG;
Fusin, 59-GGCTAAAGCTTGGCCTGAGTGCTCCAGTAGCC; 59-CGT
CCTCGAGCATCTGTGTTAGCTGGAGTG; CKR-1, 59-GCGGATCCCConclusions and Perspectives
AAAGTCCCTTGGAACCAGAG, 59-GGTCTAGACAGGCCACCATTACThis study highlights the critical importance of CKR-5
ATTCCCT.
for HIV-1 transmission. CKR-5 is likely, in addition, to
play an important role during the early phases of infec- Coreceptor Activity Analysis
tion and possibly throughout the course of the disease. Transient assay for CKR-5 coreceptor activity has been previously
described (Deng et al., 1996). In brief, 293T cells were transfectedCKR-5 could also play a role in determining the rate of
by CaPO4 coprecipitation with a mixture of pcCKR5 and pcCD4 (10disease progression. Some HIV-1-infected individuals
mg each) as described. The next day the cells were transferred toremain asymptomatic, with very low viral burdens for
24-well tissue culture dishes (1 3 104 per well), and the followingunusually long periods of time (Cao et al., 1995; Pantaleo
day the cells were infected with luciferase reporter viruses (10 ng
et al., 1995). It will be important to determine whether p24gag). Reporter viruses pseudotyped by macrophage-tropic,
such individuals tend to be heterozygous for deleted T-tropic, or amphotropic Envs were prepared by transfecting 293T
cells with NL-Luc-Env2 and the appropriate Env expression vectorCKR-5. Decreased levels of functional CKR-5 could be
(10 mg each) and quantitated as previously described and frozen inresponsible for the low viral burdens that have been
aliquots at 2808C. Lysates (100 ml) were prepared two days later andreported in these individuals. Alternatively, these indi-
luciferase activity in 20 ml was measured with commercial reagentsviduals could have CKR-5 alleles that encode receptors
(Promega) with a Packard Topcount scintillation counter. Fusin cor-
with reduced ability to mediate HIV-1 entry. Such alleles eceptor activity was measured in a stable assay as described pre-
have not yet been detected but their existence is sug- viously. In brief, retrovirus stocks were prepared from the pBABE-
puro Fusin plasmids using the method of Landau and Littman (1992).gested by previous findings that the PBMC of some EU
HOS-T4 (human osteosarcoma cells expressing human CD4) wereindividuals have a moderate decrease in their ability to
infected with the pBABE-puro viruses (2 ml supernatant). Two dayssupport macrophage-tropic HIV-1 replication (Paxton et
later the cells were selected in 1.0 mg/ml puromycin. When the cellsal., 1996).
became confluent (about 5–7 days later), the cells were infected
The presence of a nonfunctional CKR-5 allele in indi- with luciferase reporter viruses and luciferase activity was measured
viduals who are resistant to HIV-1 infection provides as described above for the transient assay.
insight into the mechanisms governing virus transmis-
sion and may in the future provide a more complete Southern and PCR Analysis of Genomic DNA
Genomic DNA was purified from cell lines and PBMC by standardunderstanding of the factors controlling disease pro-
methods. DNA (10 mg) was cleaved with restriction enzyme andgression. The lack of any obvious clinical conditions
separated by electrophoresis on 2% agarose gels. The DNA wasassociated with the absence of functional CKR-5 sug-
transferred to nitrocellulose filters and hybridized to a BamHI–SalI
gests that this receptor is dispensable. These findings cleaved CKR-5 cDNA insert labeled with [a-32P]dCTP by the random
highlight the importance of developing therapeutic primer method using commercial reagents (Boehringer-Mannheim).
agents directed against the HIV-1–CKR-5 interaction. In PCR of genomic DNA was as described for cDNA except that 0.5–1
mg of genomic DNA was used instead of reverse transcriptase prod-addition, following the changing frequencies of CKR-5
uct. Amplified products were separated on 4% MetaPhor agarosealleles in heavily infected populations may provide a
(FMC) and visualized by ethidium bromide staining.unique insight into the complex genetic interplay be-
tween this pathogen and its host.
FACS and Immunoblot Analysis
A CKR-5 expression vector containing an HA epitope-tag (Field et
al., 1988) near the amino terminus was constructed using wild-typeExperimental Procedures
or EU cell-derived CKR-5. These plasmids were mixed with an equal
amount (10 mg each) of pcCD4 (Lenburg and Landau, 1993) andRT–PCR and DNA Sequencing
Total cellular RNA was prepared using Triazol (GIBCO–BRL) ac- then used to transfect 293T cells. After two days, the 0.5 3 106
cells were stained with 0.5 mg monoclonal antibody (MAb) 12CA5cording to the manufacturer’s instructions and treated with 10 U
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(BabCo), 0.2 mg phycoerythrin-conjugated rabbit anti-mouse immu- Combadiere, C., Ahuja,S.K., and Murphy, P.M. (1995). Cloning, chro-
mosomal localization, and RNA expression of a human beta chemo-noglobulin (Boehringer-Mannheim) and 0.5 mg FITC-conjugated
anti-CD4 MAb Leu3a. Construction and characterization of the epi- kine receptor-like gene. DNA Cell. Biol. 14, 673–680.
tope-tagged wild-type CKR-5 will be reported elsewhere. The cells Connor, R.I., and Ho, D.D. (1994). Human immunodeficiency virus
(10,000)were analyzed ona Becton-Dickenson FACScaliber. Neither type 1 variants with increased replicative capacity develop during
antibody showed fluorescence levels above background on un- the asymptomatic stage before disease progression. J. Virol. 68,
transfected control 293T cells (data not shown). Tagged CKR-5 was 4400–4408.
detectedon imunoblots as describedpreviously (Paxton et al., 1993) Connor, R.I., Chen, B.K., Choe, S., and Landau, N.R. (1995). Vpr is
required for efficient replication of human immunodeficiency virus
Chemokine-Induced Signal Transduction Measurement type-1 in mononuclear phagocytes. Virology 206, 936–944.
PBMC were incubated for 4 min in phosphate-buffered saline (pH
Deng, D., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart,3.0) to remove endogenously bound chemokines. In pilot experi-
M., DiMarzio, P., Marmon, S., Sutton, R.E., Hill, C.M., et al. (1996).ments this removed 94% of the bound chemokine. The cells were
Identification of a major co-receptor for primary isolates of HIV-1.centrifuged at 500 3 G for 5 min and resuspended in Hanks’ buffer
Nature 381, 661–666.for intracellular [Ca21] measurements. Intracellular [Ca21] was mea-
Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper,sured by spectrofluoremetry with Fura 2 as described (Neote et al.,
S.C., Parmentier, M., Collman, R.G., and Doms, R.W. (1996). A dual-1993), with the following modifications. Fura 2 was used at a 5 mM
tropic primary HIV-1 isolate that uses Fusin and the b-chemokineand 3 3 106 cells were used per assay.
receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85,
1149–1158.HIV-1 Growth Curves
Replication of HIV-1 was measured as described previously (Paxton Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagas-
et al., 1996). In brief, PBMC (2 3 105) were from Ficoll purified hima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., and
leukocytes. The CD41 cells were purified and stimulated with phyto- Paxton, W.A. (1996). HIV-1 entry into CD41 cells is mediated by the
hemagglutinin for three days. HIV-1 SF162 (600 TCID) was added chemokine receptor CC-CKR-5. Nature 381, 667–673.
for at least 4 hr, and the cells were washed three times to remove Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A. (1996). HIV-1
input virus. Samples were removed for p24gag quantitation by com- entry cofactor: functional cDNA cloning of a seven-transmembrane
mercial ELISA (Abbot) at indicated days postinfection. G protein–coupled receptor. Science 272, 872–877.
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